Insider · CIK 0001986112

Aminov Erez

Reports to the SEC for 2 companies · MIAMI, FL

sec.gov

Transactions

Companies

Filings

CIK

0001986112

Forms 4 and 5

Insider transactions

38 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-21	TELOTelomir Pharmaceuticals, Inc. · Incentive Stock Options (right to buy)A Award	Director, CEO and Chairman	AAward	+1.96M sh	—	—	1,960,170
2026-05-21	TELOTelomir Pharmaceuticals, Inc. · Non-Qualified Stock Options (right to buy)A Award	Director, CEO and Chairman	AAward	+2M sh	—	—	2,000,000
2026-05-21	TELOTelomir Pharmaceuticals, Inc. · Incentive Stock Options (right to buy)D Disposition to Issuer	Director, CEO and Chairman	DDisposition to Issuer	−1.96M sh	—	—	0
2026-05-21	TELOTelomir Pharmaceuticals, Inc. · Non-Qualified Stock Options (right to buy)D Disposition to Issuer	Director, CEO and Chairman	DDisposition to Issuer	−2M sh	—	—	0
2026-04-22	TELOTelomir Pharmaceuticals, Inc.J Other	Director, CEO and Chairman	JOther	+7.32M sh	$1.37	+$10M	7,319,710
2026-03-30	MIRAMIRA PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+83.5K sh	—	—	83,500
2025-12-17	MIRAMIRA PHARMACEUTICALS, INC. · Stock Options (right to buy)A Award	Director, Chief Executive Officer	AAward	+3.16M sh	—	—	3,155,170
2025-10-16	MIRAMIRA PHARMACEUTICALS, INC.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+235K sh	$1.16	+$272K	3,827,259
2025-10-16	MIRAMIRA PHARMACEUTICALS, INC. · Stock Options (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+379K sh	—	—	379,000
2025-10-16	MIRAMIRA PHARMACEUTICALS, INC. · Stock Options (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+235K sh	—	—	234,595
2025-10-16	MIRAMIRA PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−614K sh	$2.11	−$1.29M	3,592,666
2025-10-16	MIRAMIRA PHARMACEUTICALS, INC.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+379K sh	$0.84	+$318K	4,206,259
2025-10-01	MIRAMIRA PHARMACEUTICALS, INC.A Award	Director, Chief Executive Officer	AAward	+2.69M sh	—	—	3,530,156
2025-09-18	MIRAMIRA PHARMACEUTICALS, INC. · Stock Options (right to buy)A Award	Director, Chief Executive Officer	AAward	+150K sh	—	—	150,000
2025-09-18	MIRAMIRA PHARMACEUTICALS, INC. · Stock Options (right to buy)A Award	Director, Chief Executive Officer	AAward	+150K sh	—	—	150,000
2025-08-29	MIRAMIRA PHARMACEUTICALS, INC.A Award	Director, Chief Executive Officer	AAward	+62.5K sh	$1.37	+$85.6K	844,700
2025-05-28	TELOTelomir Pharmaceuticals, Inc. · Non-Qualified OptionsA Award	Director, CEO and Chairman	AAward	+2M sh	—	—	2,000,000
2025-05-28	TELOTelomir Pharmaceuticals, Inc. · Restricted Stock Units (RSUs)A Award	Director, CEO and Chairman	AAward	+400K sh	—	—	400,000
2025-03-26	MIRAMIRA PHARMACEUTICALS, INC.A Award	Director, Chief Executive Officer	AAward	+62.5K sh	$1.45	+$90.6K	3,592,666
2025-03-26	MIRAMIRA PHARMACEUTICALS, INC.A Award	Director, Chief Executive Officer	AAward	+62.5K sh	$1.45	+$90.6K	3,530,166
2024-12-09	MIRAMIRA PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+500K sh	—	—	500,000
2024-12-09	MIRAMIRA PHARMACEUTICALS, INC. · Stock Options (right to buy)A Award	Director, Chief Executive Officer	AAward	+2M sh	—	—	2,000,000
2024-11-20	MIRAMIRA PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−44.6K sh	$1.27	−$56.6K	1,061,200
2024-11-19	MIRAMIRA PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer	SSale	−55.4K sh	$1.39	−$77K	1,105,790
2024-08-27	TELOTelomir Pharmaceuticals, Inc. · Incentive Stock Options (right to buy)A Award	Director, CEO and Chairman	AAward	+1.96M sh	—	—	1,960,170
2024-08-19	TELOTelomir Pharmaceuticals, Inc.S Sale	Director, CEO and Chairman	SSale	−200 sh	$6.20	−$1,240	29,600
2024-08-19	TELOTelomir Pharmaceuticals, Inc.S Sale	Director, CEO and Chairman	SSale	−200 sh	$6.01	−$1,202	29,600
2024-05-28	MIRAMIRA PHARMACEUTICALS, INC. · Incentive Stock Options (right to buy)A Award	Director, Chief Executive Officer	AAward	+379K sh	—	—	629,000
2024-05-21	MIRAMIRA PHARMACEUTICALS, INC.P Purchase	Director, Chief Executive Officer	PPurchase	+500 sh	$1.02	+$510	377,000
2024-05-21	MIRAMIRA PHARMACEUTICALS, INC.P Purchase	Director, Chief Executive Officer	PPurchase	+800 sh	$0.97	+$776	382,200
2024-05-21	MIRAMIRA PHARMACEUTICALS, INC.P Purchase	Director, Chief Executive Officer	PPurchase	+800 sh	$1.01	+$808	381,400
2024-05-21	MIRAMIRA PHARMACEUTICALS, INC.P Purchase	Director, Chief Executive Officer	PPurchase	+600 sh	$0.87	+$522	380,600
2024-05-21	MIRAMIRA PHARMACEUTICALS, INC.P Purchase	Director, Chief Executive Officer	PPurchase	+1,000 sh	$0.85	+$850	380,000
2024-05-21	MIRAMIRA PHARMACEUTICALS, INC.P Purchase	Director, Chief Executive Officer	PPurchase	+2,000 sh	$0.84	+$1,680	379,000
2024-05-21	MIRAMIRA PHARMACEUTICALS, INC.P Purchase	Director, Chief Executive Officer	PPurchase	+1,000 sh	$1.03	+$1,030	376,500
2024-05-21	MIRAMIRA PHARMACEUTICALS, INC.P Purchase	Director, Chief Executive Officer	PPurchase	+2,000 sh	$1.00	+$2,000	375,500
2024-03-26	MIRAMIRA PHARMACEUTICALS, INC. · Incentive Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+300K sh	—	—	250,000
2023-08-17	MIRAMIRA PHARMACEUTICALS, INC. · Stock OptionsA Award	Director, Chief Executive Officer	AAward	+150K sh	—	—	150,000

Recent filings

Accepted (ET)
May 224
Aminov Erez0001493152-26-025116
SEC(opens sec.gov)
Apr 244
Aminov Erez0001493152-26-018911
SEC(opens sec.gov)
Apr 14
Aminov Erez0001493152-26-014697
SEC(opens sec.gov)
Feb 175
Aminov Erez0001493152-26-007226
SEC(opens sec.gov)
Oct 34
Aminov Erez0001493152-25-016957
SEC(opens sec.gov)
Sep 184
Aminov Erez0001493152-25-014114
SEC(opens sec.gov)
Sep 34
Aminov Erez0001641172-25-026388
SEC(opens sec.gov)
May 304
Aminov Erez0001641172-25-013148
SEC(opens sec.gov)

Companies

Address

C/O TELOMIR PHARMACEUTICALS, INC. 100 SE 2ND ST, SUITE 200 #1009

MIAMI, FL, 33131